Product Information
ALPRAZOLAM ER 2 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.1985 per EA under NDC 00228308706. Its NADAC has been published 649 times since Nov 28, 2013.
FDA first approved this application on Feb 13, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228308706
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
4/22/2026
Active Ingredients
ALPRAZOLAMApproval Type
Generic (ANDA)
FDA Application
ANDA078056FDA Approved
2/13/2007
TE Code
AB
On Market Since
3/12/2007
Pharmacological Classes
Price Statistics
The NADAC for ALPRAZOLAM ER 2 MG TABLET has been published 649 times since Nov 28, 2013, and over the history we have for it it has declined 56.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1985 per EA |
|---|---|
| All-time high | $0.5835 (Jul 16, 2014) |
| All-time low | $0.1587 (Nov 20, 2024) |
| 52-week high | $0.2230 |
| 52-week low | $0.1891 |
| Median price | $0.2962 |
| Average price | $0.3397 |
| Largest weekly change | +44.3% (Nov 17, 2021) |
| Weeks tracked | 649 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
+5.0%
1Y
-11.0%
3Y
-20.3%
5Y
-31.5%
All
-56.2%
Last surveyed Apr 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALPRAZOLAM ER 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALPRAZOLAM ER 2 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.1985 per EA (NDC 00228308706), effective Apr 29, 2026.
How has the price of ALPRAZOLAM ER 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALPRAZOLAM ER 2 MG TABLET has declined 56.2%. It has been tracked across 649 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALPRAZOLAM ER 2 MG TABLET?
Since Nov 28, 2013, the NADAC for ALPRAZOLAM ER 2 MG TABLET has ranged from a low of $0.1587 (Nov 20, 2024) to a high of $0.5835 (Jul 16, 2014), with a median of $0.2962 per EA.
Are there cheaper alternatives to ALPRAZOLAM ER 2 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALPRAZOLAM 2 MG TABLET, is $0.0485 per EA — about 76% below ALPRAZOLAM ER 2 MG TABLET.
Who manufactures ALPRAZOLAM ER 2 MG TABLET?
ALPRAZOLAM ER 2 MG TABLET (NDC 00228308706) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.